Results 91 to 100 of about 24,187 (191)
Analytical Science Advances, Volume 7, Issue 1, June 2026.ABSTRACT Steroids are critical for numerous physiological processes; disruption in their metabolism is associated with numerous endocrine disorders. Steroid quantification is essential to improve the understanding and diagnosis of these pathologies. Historically, urinary steroid profiling has been performed using low‐throughput gas chromatography mass ...
Joshua T. Bain +4 more
wiley +1 more source
Is diabetes in Cushing's syndrome only a consequence of hypercortisolism? [PDF]
, 2014 OBJECTIVE: Diabetes mellitus (DM) is one of the most frequent complications of Cushing's syndrome (CS). The aim of this study was to define the changes in insulin sensitivity and/or secretion in relation to glucose tolerance categories in newly ...
AMATO, Marco Calogero +7 more
core +1 more source
Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.ABSTRACT Rush Medical College implemented a new, integrated pre‐clerkship curriculum. Pharmacology was integrated with other basic sciences into a flipped, small‐group, case‐based structure. This report describes the main features of the pharmacology curriculum for pharmacology directors to have a template.
Brinda Desai Bradaric +3 more
wiley +1 more source
Case Reports in Dermatology, 2011 We describe a 50-year-old Japanese patient with dermatofibrosarcoma protuberans (DFSP) rapidly growing after bilateral adrenalectomy for Cushing’s syndrome that reduced the serum level of cortisol from 17.1 to 0.8 mg/dl.
Sadanori Furudate +3 more
doaj +1 more source
Aumento da probabilidade diagnóstica de síndrome de cushing subclínica em uma amostra populacional de pacientes adultos obesos com diabetes mellitus tipo 2 [PDF]
, 2007 Endogenous Cushing s Syndrome (CS) is unusual. Patients with subclinical CS (SCS) present altered cortisol dynamics without obvious manifestations. CS occurs in 2-3% of obese poorly controlled diabetics.
Caetano, Maria Silvia S. +2 more
core +3 more sources
Clinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1350-1361, May 2026.Regional differences in approved drug dosages and administration are shaped by complex factors, including clinical data, prior regulatory decisions, and region‐specific considerations. This study investigated how such factors are associated with variations in approved doses across the United States Food and Drug Administration (FDA), European Medicines
Sachiko Mita, Shunsuke Ono
wiley +1 more source
Invasive fungal infections in endogenous Cushing’s syndrome
Infectious Disease Reports, 2010 Cushing’s syndrome is a condition characterized by elevated cortisol levels that can result from either augmented endogenous production or exogenous administration of corticosteroids.
Rafael Selbach Scheffel +6 more
doaj +1 more source
Efeito do tratamento com ketoconazole por um mês na liberação de GH, cortisol e ACHT após administração de GHrelin, GHRP-6 e GHRH em pacientes com síndrome de cushing [PDF]
, 2007 GH responses to ghrelin, GHRP-6, and GHRH in Cushing s disease (CD) are markedly blunted. There is no data about the effect of reduction of cortisol levels with steroidogenesis inhibitors, like ketoconazole, on GH secretion in CD.
Correa-Silva, Silvia R. +4 more
core +3 more sources
IJU Case Reports, Volume 9, Issue 3, May 2026.ABSTRACT Introduction Ectopic adrenocortical adenomas that produce adrenal hormones and mimic renal cell carcinoma are extremely rare. Case Presentation A 49‐year‐old woman underwent partial nephrectomy of the upper pole of the kidney following a clinical diagnosis of renal cell carcinoma.
Kentaro Arinami +8 more
wiley +1 more source
Journal of Medical Case Reports, 2012 Introduction Adrenocorticotropic hormone-independent macronodular adrenal hyperplasia, characterized by bilateral macronodular adrenal hypertrophy and autonomous cortisol production, is a rare cause of Cushing’s syndrome.
Ito Toshiki +9 more
doaj +1 more source